DE69925301D1 - Zusammensetzung von riluzol und alpha-tocopherol - Google Patents

Zusammensetzung von riluzol und alpha-tocopherol

Info

Publication number
DE69925301D1
DE69925301D1 DE69925301T DE69925301T DE69925301D1 DE 69925301 D1 DE69925301 D1 DE 69925301D1 DE 69925301 T DE69925301 T DE 69925301T DE 69925301 T DE69925301 T DE 69925301T DE 69925301 D1 DE69925301 D1 DE 69925301D1
Authority
DE
Germany
Prior art keywords
riluzole
tocopherol
alpha
composition
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69925301T
Other languages
English (en)
Other versions
DE69925301T2 (de
Inventor
Michel Dib
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69925301D1 publication Critical patent/DE69925301D1/de
Publication of DE69925301T2 publication Critical patent/DE69925301T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DE69925301T 1998-11-13 1999-11-09 Zusammensetzung von riluzol und alpha-tocopherol Expired - Lifetime DE69925301T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9814250 1998-11-13
FR9814250A FR2785808B1 (fr) 1998-11-13 1998-11-13 Association riluzole et alpha-tocopherol
PCT/FR1999/002753 WO2000028992A1 (fr) 1998-11-13 1999-11-09 Association riluzole et alpha-tocopherol

Publications (2)

Publication Number Publication Date
DE69925301D1 true DE69925301D1 (de) 2005-06-16
DE69925301T2 DE69925301T2 (de) 2006-01-26

Family

ID=9532674

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69925301T Expired - Lifetime DE69925301T2 (de) 1998-11-13 1999-11-09 Zusammensetzung von riluzol und alpha-tocopherol

Country Status (23)

Country Link
US (2) US6642262B2 (de)
EP (1) EP1128829B1 (de)
JP (1) JP4693241B2 (de)
KR (1) KR100641472B1 (de)
CN (1) CN1177587C (de)
AT (1) ATE295168T1 (de)
AU (1) AU776242B2 (de)
BR (1) BR9915292A (de)
CA (1) CA2350671C (de)
CZ (1) CZ298808B6 (de)
DE (1) DE69925301T2 (de)
DK (1) DK1128829T3 (de)
EA (1) EA003671B1 (de)
ES (1) ES2239858T3 (de)
FR (1) FR2785808B1 (de)
HK (1) HK1041220B (de)
HU (1) HU226067B1 (de)
IL (1) IL142708A0 (de)
NO (1) NO328349B1 (de)
PT (1) PT1128829E (de)
TR (1) TR200101346T2 (de)
WO (1) WO2000028992A1 (de)
ZA (1) ZA200103810B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786101B1 (fr) * 1998-11-24 2002-07-05 Aventis Laboratoire Utilisation de la nicergoline dans le traitement de la spasticite
JPWO2007046347A1 (ja) * 2005-10-18 2009-04-23 小野薬品工業株式会社 筋萎縮性側索硬化症患者の運動神経保護用医薬
US20070099156A1 (en) * 2005-10-28 2007-05-03 Jeff Wagner Self-etching dental primer compositions and methods and systems utilizing such compositions
FR2957077B1 (fr) * 2010-03-02 2012-04-13 Univ Dauvergne Clermont I Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux
WO2014145776A2 (en) * 2013-03-15 2014-09-18 Baylor College Of Medicine Msp and its receptors in the therapy of amyotrophic lateral sclerosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688138B1 (fr) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
US5843641A (en) * 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
US6380252B1 (en) * 1996-07-05 2002-04-30 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
US5780489A (en) * 1996-08-21 1998-07-14 Brooks; Benjamin Rix Method for treating amyotrophic lateral sclerosis
JP3889844B2 (ja) * 1997-02-10 2007-03-07 龍兒 梶 筋萎縮性側索硬化症治療剤
FR2782008B1 (fr) * 1998-08-07 2003-04-25 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique

Also Published As

Publication number Publication date
CN1326348A (zh) 2001-12-12
WO2000028992A1 (fr) 2000-05-25
ZA200103810B (en) 2002-08-12
US20020019426A1 (en) 2002-02-14
PT1128829E (pt) 2005-07-29
DE69925301T2 (de) 2006-01-26
DK1128829T3 (da) 2005-08-29
JP4693241B2 (ja) 2011-06-01
NO328349B1 (no) 2010-02-01
CZ20011561A3 (cs) 2001-08-15
HUP0105301A2 (hu) 2002-05-29
KR20010080407A (ko) 2001-08-22
EP1128829A1 (de) 2001-09-05
CA2350671A1 (fr) 2000-05-25
KR100641472B1 (ko) 2006-10-31
AU1165500A (en) 2000-06-05
CN1177587C (zh) 2004-12-01
CZ298808B6 (cs) 2008-02-06
HU226067B1 (en) 2008-04-28
BR9915292A (pt) 2001-08-07
TR200101346T2 (tr) 2002-05-21
ATE295168T1 (de) 2005-05-15
US6642262B2 (en) 2003-11-04
AU776242B2 (en) 2004-09-02
HUP0105301A3 (en) 2006-07-28
HK1041220B (zh) 2005-07-22
EP1128829B1 (de) 2005-05-11
HK1041220A1 (en) 2002-07-05
FR2785808A1 (fr) 2000-05-19
JP2002529506A (ja) 2002-09-10
IL142708A0 (en) 2002-03-10
CA2350671C (fr) 2010-05-04
ES2239858T3 (es) 2005-10-01
NO20012308D0 (no) 2001-05-10
EA003671B1 (ru) 2003-08-28
NO20012308L (no) 2001-05-10
FR2785808B1 (fr) 2002-12-06
US20030125363A1 (en) 2003-07-03
EA200100530A1 (ru) 2001-10-22

Similar Documents

Publication Publication Date Title
DK1214936T3 (da) Anvendelse af thiazolidin- eller pyrrolidinderivater af aminosyrer som antihyperglykæmiske midler
DK0797439T3 (da) Anvendelse af pramipexol som et neurobeskyttende middel
EA199800667A1 (ru) Новые фенантридины
NO912630L (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler
NO954427D0 (no) Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
ES2127397T3 (es) Sulfonamidas y sus derivados que modulan la actividad de la endotelina.
ATE196761T1 (de) Inhibitoren retroviraler proteasen
BR0317715A (pt) Composições e processos de uso de collajolie
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
ITRM940150A0 (it) Procedimento per il trattamento di acque di scarico fortemente colorate.
DK0804421T3 (da) 2-((Dihydro)pyrazolyl-3'-oxymethylen)-anilider som skadedyrsbekæmpelsesmidler og fungicider
AU6613896A (en) Chemical compounds
DK0572166T3 (da) Hidtil ukendte 7beta-substitueret-4-aza-5beta-androstan-3-oner som 5beta-reduktaseinhibitorer
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
ATE448774T1 (de) Kosmetische zusammensetzung enthaltend ein siegesbeckia extrakt und ein lipopeptid
ATE359793T1 (de) 2-methyl-thieno-benzodiazepin formulierung
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
PT941975E (pt) Cimento para injeccao contendo inibidores de corrosao
ATE295168T1 (de) Zusammensetzung von riluzol und alpha-tocopherol
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
SE9704770D0 (sv) New use
IL127930A0 (en) Verapamil as a medicament for the treatment of angina
FR2778102B1 (fr) Utilisation d'oligomeres procyanidoliques (opc) ou d'anthocyanosides a titre d'agents anti-urease
SE9303060L (sv) Löstagbar stoppanordning
ECSP972052A (es) Quinoxalinadionas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC